AU Small Finance Bank is showing robust bullish momentum, consistently trading higher and finding support at its 20-Day EMA. The stock is c...

Indian exporters, particularly in the chemicals, textiles, and handicrafts sectors, are experiencing a notable increase in inquiries from U...

Indian markets experienced a volatile yet narrow trading range, concluding marginally lower as consolidation persists. Analysts await a dec...

Despite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...

Indian equities ended lower for the second straight session as benchmarks slipped on expiry-day volatility, though broader markets advanced...

Gold and silver prices tumbled over 1% on Tuesday, driven by Middle East tensions and anticipated US Federal Reserve rate hikes to combat i...

Gold and silver prices traded lower on MCX on Monday as renewed Middle East tensions and expectations of further US Federal Reserve rate hi...

Geojit's Anand James anticipates a stable Nifty expiry with controlled movements, not sharp volatility. He advises buying Mahindra & Mahind...

Indian markets head into a crucial week with investors tracking Q1 business updates, June F&O expiry, auto sales data, FII flows, crude oil...

Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

India is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Hyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...

Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...